Laura Ivers

Affiliations
  • Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Dublin 9, Ireland.

Publications (1)

HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer.

Investigational new drugs
Avec: Alexandra Canonici , Laura Ivers , Neil T Conlon , Kasper Pedersen , Nicola Gaynor , Brigid C Browne , Neil A O'Brien , Giuseppe Gullo , Denis M Collins , Norma O'Donovan , John Crown

Réseau de co-auteurs

Alexandra Canonici 1 collaboration
Neil T Conlon 1 collaboration
Kasper Pedersen 1 collaboration
Nicola Gaynor 1 collaboration
Brigid C Browne 1 collaboration
Neil A O'Brien 1 collaboration
Giuseppe Gullo 1 collaboration
Denis M Collins 1 collaboration
Norma O'Donovan 1 collaboration
John Crown 1 collaboration